6th CNS Partnering & Deal-Making Conference 2013

The conference has traditionally provided a forum for global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations and learn about relevant CNS disease issues and partnerships that will affect the industry.

While all of the above will once again hold true for this year’s meeting, this year we will focus on how we can broaden our understanding of what the words "effective partnerships" can mean. Together, we will explore and review collaborations between industry and academia, the formation of research consortia, and the growing role of patient groups and non-profit organizations in accelerating research.